louisiana glp-1 stomach paralysis law firm semaglutide nausea attorney in Louisiana woman sues drug makers of Ozempic and Mounjaro over 'stomach paralysis' The GLP-1 RA Legal Timeline:

Exenatide: a new option for the treatment of type 2 diabetes

Tyrphostin ag490 reduces napdh oxidase activity and expression in the aorta of hypercholesterolemic apolipoprotein e-deficient mice

Topics discussed in this article: References Wu, J

You may have seen [00:25:00] headlines that are like in people who are overweight or obese and have established heart disease but no diabetes

What we tried to do with the development of Oikos Fusion was really lean into the nutrition science to understand what nutrients people taking a GLP-1 drug would be most likely be deficient in due to their lower caloric or energy intake, and really understand from a nutrition perspective, how we could uniquely support them, she said